The pharmaceutical and biotechnology sector has performed well in recent years, primarily by virtue of attractive fundamentals.
Another UK Equity Income fund to be ejected
Firms asked if other income sectors require change
How have they performed?
One-year yield falling short of requirements
Oil, industrials and banks dividends at risk